评 Hill 等人的文章：打破障碍——增加救命的阿片类药物使用障碍治疗药物的获取途径以拯救生命。
Commentary on Hill et al.: Breaking down barriers-increasing access to lifesaving opioid use disorder medications to save lives.
机构信息
Division of Emergency Medicine, Boston Children's Hospital, Boston, MA, USA.
Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
出版信息
Addiction. 2021 Jun;116(6):1512-1513. doi: 10.1111/add.15375. Epub 2021 Jan 6.
Abstract
Numerous barriers exist for patients attempting to access treatment for opioid-use disorder and/or naloxone, with geographical, racial, and age-related differences exacerbating these hardships.
摘要
许多患者在尝试获得阿片类药物使用障碍和/或纳洛酮治疗时面临障碍，地理位置、种族和年龄相关差异加剧了这些困难。
相似文献
1
Commentary on Hill et al.: Breaking down barriers-increasing access to lifesaving opioid use disorder medications to save lives.评 Hill 等人的文章：打破障碍——增加救命的阿片类药物使用障碍治疗药物的获取途径以拯救生命。
Addiction. 2021 Jun;116(6):1512-1513. doi: 10.1111/add.15375. Epub 2021 Jan 6.
2
Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in Texas, USA.美国德克萨斯州社区药店中美沙酮/纳洛酮膜和纳洛酮鼻喷剂的供应情况。
Addiction. 2021 Jun;116(6):1505-1511. doi: 10.1111/add.15314. Epub 2020 Nov 22.
3
Assessing perceptions about medications for opioid use disorder and Naloxone on Twitter.评估关于阿片类药物使用障碍和纳洛酮药物在 Twitter 上的认知。
J Addict Dis. 2021 Jan-Mar;39(1):37-45. doi: 10.1080/10550887.2020.1811456. Epub 2020 Aug 24.
4
Pharmacists' and technicians' perceptions and attitudes toward dispensing buprenorphine/ naloxone to patients with opioid dependence.药剂师和技术人员对向阿片类药物依赖患者配发丁丙诺啡/纳洛酮的看法和态度。
J Am Pharm Assoc (2003). 2005 Jan-Feb;45(1):23-32. doi: 10.1331/1544345052843200.
5
Ensuring buprenorphine access in rural community pharmacies to prevent overdoses.确保农村社区药房能提供丁丙诺啡以预防药物过量。
J Am Pharm Assoc (2003). 2022 Mar-Apr;62(2):588-597.e2. doi: 10.1016/j.japh.2021.10.002. Epub 2021 Oct 8.
6
Pharmacy-related buprenorphine access barriers: An audit of pharmacies in counties with a high opioid overdose burden.与药房相关的丁丙诺啡获取障碍：对高阿片类药物过量负担县的药房进行审计。
Drug Alcohol Depend. 2021 Jul 1;224:108729. doi: 10.1016/j.drugalcdep.2021.108729. Epub 2021 Apr 24.
7
Impact of naloxone education for patients receiving buprenorphine-containing prescriptions indicated for opioid use disorder at an independent community pharmacy.在独立社区药房中，对接受含有丁丙诺啡处方的患者进行纳洛酮教育对阿片类药物使用障碍的影响。
J Am Pharm Assoc (2003). 2020 Nov-Dec;60(6):e205-e214. doi: 10.1016/j.japh.2020.07.015. Epub 2020 Aug 14.
8
The effects of buprenorphine/naloxone maintenance treatment on sexual dysfunction, sleep and weight in opioid use disorder patients.丁丙诺啡/纳洛酮维持治疗对阿片类药物使用障碍患者性功能障碍、睡眠和体重的影响。
Psychiatry Res. 2019 Feb;272:450-453. doi: 10.1016/j.psychres.2018.12.153. Epub 2018 Dec 29.
9
Geographic and specialty distribution of US physicians trained to treat opioid use disorder.接受过治疗阿片类药物使用障碍培训的美国医生的地理分布和专业分布。
Ann Fam Med. 2015 Jan-Feb;13(1):23-6. doi: 10.1370/afm.1735.
10
Association between buprenorphine/naloxone and high-dose opioid analgesic prescribing in Kentucky, 2012-2017.肯塔基州 2012-2017 年丁丙诺啡/纳洛酮与大剂量阿片类镇痛药处方之间的关联。
Drug Alcohol Depend. 2019 Dec 1;205:107606. doi: 10.1016/j.drugalcdep.2019.107606. Epub 2019 Oct 3.
引用本文的文献
1
Association of Prescription Drug Monitoring Programs With Opioid Prescribing and Overdose in Adolescents and Young Adults.处方药物监测项目与青少年和年轻成年人阿片类药物处方和过量使用的关联。
Ann Emerg Med. 2023 Apr;81(4):429-437. doi: 10.1016/j.annemergmed.2022.11.003. Epub 2023 Jan 18.
本文引用的文献
1
Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in Texas, USA.美国德克萨斯州社区药店中美沙酮/纳洛酮膜和纳洛酮鼻喷剂的供应情况。
Addiction. 2021 Jun;116(6):1505-1511. doi: 10.1111/add.15314. Epub 2020 Nov 22.
2
Trends in the Use of Buprenorphine in US Emergency Departments, 2002-2017.2002-2017 年美国急诊科丁丙诺啡使用趋势。
JAMA Netw Open. 2020 Oct 1;3(10):e2021209. doi: 10.1001/jamanetworkopen.2020.21209.
3
The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update.美国成瘾医学协会阿片类物质使用障碍治疗国家实践指南：2020年重点更新
J Addict Med. 2020 Mar/Apr;14(2S Suppl 1):1-91. doi: 10.1097/ADM.0000000000000633.
4
Patients With Opioid Use Disorder Deserve Trained Providers.患有阿片类药物使用障碍的患者需要训练有素的医疗服务提供者。
Ann Intern Med. 2020 Jun 2;172(11):772-773. doi: 10.7326/L20-0081.
5
Assessment of Racial and Ethnic Disparities in the Use of Medication to Treat Opioid Use Disorder Among Pregnant Women in Massachusetts.评估马萨诸塞州孕妇使用药物治疗阿片类药物使用障碍的种族和民族差异。
JAMA Netw Open. 2020 May 1;3(5):e205734. doi: 10.1001/jamanetworkopen.2020.5734.
6
Association of Racial/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States.美国各县种族/民族隔离与阿片类药物使用障碍治疗能力的关系。
JAMA Netw Open. 2020 Apr 1;3(4):e203711. doi: 10.1001/jamanetworkopen.2020.3711.
7
Receipt of Addiction Treatment After Opioid Overdose Among Medicaid-Enrolled Adolescents and Young Adults.接受阿片类药物过量治疗的 Medicaid 参保青少年和年轻人。
JAMA Pediatr. 2020 Mar 1;174(3):e195183. doi: 10.1001/jamapediatrics.2019.5183. Epub 2020 Mar 2.
8
Youth Access to Naloxone: The Next Frontier?青少年获取纳洛酮：下一个前沿领域？
J Adolesc Health. 2019 Nov;65(5):571-572. doi: 10.1016/j.jadohealth.2019.08.005.
9
Availability of Naloxone in Pharmacies and Knowledge of Pharmacy Staff Regarding Dispensing Naloxone to Younger Adolescents.药店纳洛酮的供应情况以及药店员工对向未成年青少年分发纳洛酮的了解情况。
J Adolesc Health. 2019 Nov;65(5):698-701. doi: 10.1016/j.jadohealth.2019.07.009. Epub 2019 Sep 17.
10
Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States?在医疗实践中开具丁丙诺啡治疗阿片类药物使用障碍：基于诊室的门诊治疗能否解决美国的阿片类药物危机？
Addiction. 2019 Nov;114(11):1992-1999. doi: 10.1111/add.14733. Epub 2019 Jul 25.
Zotero 插件